Trump Tariff Plan Sinks Pharma Stocks, Aurobindo Down 4%

"Renewed concerns over US tariffs on generic pharmaceutical imports weighed on investor sentiment," said Ponmudi R, CEO of Enrich Money. India is the largest exporter of generic medicines to the US.

The timeline is staggered. The zero-rate period runs through July 2028, followed by a 100% rate through July 2029. The 200% rate starts in August 2029. Sun Pharma and Dr Reddy's operate US manufacturing plants. Aurobindo also has a US facility. The tariff schedule gives these companies roughly two years to expand capacity before the first increase.

Trump described the tariff as a "penalty to those Companies that decide not to build Plant and Equipment within the stated period of time given to them." The US relies heavily on imports for generic drugs, with India as the largest supplier. The post did not detail exemptions or a process for companies to qualify for the lower rate.